A11- Notice of Intent to Sole Source_CO reviewed.pdf

The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to Evolva AG to develop and test nootkatone-based products to repel and kill ticks. The purpose of the contract is to continue services to develop and test nootkatone-based products to repel and kill ticks. Only one responsible source and no other supplies or services will satisfy agency requirements, as Evolva AG is a joint owner with CDC on patents for the use of Nootkatone to repel and kill arthropod pathogen vectors. We therefore conclude that the only vendor option for the service contract is Evolva AG. This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist Ashley Williams at dal3@cdc.gov by 12:00 PM EST on April 3, 2024.